A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive Disorder.

Autor: Chen JCC; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand.; Corresponding author: Joseph C. C. Chen, MSc, School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland 1023, New Zealand (joseph.chen@auckland.ac.nz)., Sumner RL; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand., Naga VK; Acute Adult North Community Mental Health Services, Waitemata District Health Board, Takapuna, Auckland, New Zealand., Hoeh N; Department of Psychological Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand., Ayeni HA; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, Grafton, Auckland, New Zealand., Singh V; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, Grafton, Auckland, New Zealand., Wilson A; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, Grafton, Auckland, New Zealand., Campbell D; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, Grafton, Auckland, New Zealand., Sundram F; Department of Psychological Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand., Muthukumaraswamy SD; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand.

Publikováno v: The Journal of clinical psychiatry [J Clin Psychiatry] 2022 Aug 15; Vol. 83 (5). Date of Electronic Publication: 2022 Aug 15.

A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder.

Autor: Chen JCC; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Sumner RL; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand., Krishnamurthy Naga V; Acute Adult North Community Mental Health Services, Waitemata District Health Board, 44 Taharoto Road, Takapuna, Auckland, 0622, New Zealand., Hoeh N; Department of Psychological Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 2 Park Road, Grafton, Auckland, 1023, New Zealand., Ayeni HA; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand., Singh V; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand., Sundram F; Department of Psychological Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 2 Park Road, Grafton, Auckland, 1023, New Zealand., Campbell D; Department of Anaesthesiology and Perioperative Medicine, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand., Muthukumaraswamy S; School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland, 1023, New Zealand. sd.muthu@auckland.ac.nz.

Publikováno v: Trials [Trials] 2020 Feb 10; Vol. 21 (1), pp. 157. Date of Electronic Publication: 2020 Feb 10.